Background illustration for clinical trials search

Multiple Sclerosis Clinical Trials

Browse 309 multiple sclerosis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders

for
Multiple Sclerosis, Neuromyelitis Optica,
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT05982925

Recruiting

Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve

for
Demyelinating Diseases, Multiple Sclerosis,
Location: Rochester MN
Sponsor: Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul

Sex: All

Age: 18+

Code: NCT05605951

Recruiting

A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis

for
Secondary Progress Multiple Sclerosis, Multiple Sclerosis
Location: San Diego CA
Sponsor: Immune Response BioPharma, Inc.

Sex: All

Age: 18 - 50

Code: NCT02057159

Phase 2, Phase 3, Recruiting

Clinical Importance of Glucose Regulation in Relapsing MS

for
Relapsing Remitting Multiple Sclerosis,
Location: Charlottesville VA
Sponsor: University of Virginia

Sex: All

Age: 18 - 59

Code: NCT03004079

Recruiting

Intermittent Hypoxia in Persons With Multiple Sclerosis

for
Multiple Sclerosis, Multiple Sclerosis-Relapsing-Remitting,
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab

Sex: All

Age: 18 - 70+

Code: NCT06276634

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

for
Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive,
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab

Sex: All

Age: 18 - 70+

Code: NCT06516458

Recruiting

Exercise Effects in Multiple Sclerosis

for
Multiple Sclerosis, Primary Progressive,
Location: Regina
Sponsor: University of Regina

Sex: All

Age: 18+

Code: NCT05496881

Recruiting

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis

for
Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting,
Location: Cleveland OH
Sponsor: Cionic, Inc.

Sex: All

Age: 22 - 70+

Code: NCT05964829

Recruiting

Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis

for
Clinically Isolated Syndrome,
Location: Montreal
Sponsor: McGill University

Sex: All

Age: 18 - 65

Code: NCT05277740

Recruiting

Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

for
Multiple Sclerosis, RRMS, Relapsing Remitting MS
Location: San Francisco CA
Sponsor: Ari Green

Sex: All

Age: 18+

Code: NCT07510607

Phase 2, Recruiting

A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis

for
Multiple Sclerosis, Multiple Sclerosis, Primary Progressive,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18 - 65

Code: NCT06138132

Phase 1, Recruiting

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

for
Primary Progressive Multiple Sclerosis,
Location: New York NY, Durham NC, Cincinnati OH, St Louis MO,
Sponsor: Tr1X, Inc.

Sex: All

Age: 18 - 65

Code: NCT07477639

Phase 1, Phase 2, Recruiting

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

for
Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting,
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab

Sex: All

Age: 18 - 70+

Code: NCT06390930

Recruiting

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

for
Multiple Sclerosis (MS),
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18 - 55

Code: NCT05359653

Phase 1, Phase 2, Recruiting

A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab

for
Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting
Location: West Hollywood CA
Sponsor: Berkovich, Regina MD, PhD Inc.

Sex: All

Age: 21 - 65

Code: NCT04048577

Recruiting
New

Investigating the Impact of Treadmill-integrated Virtual Reality Training on Walking Outside the Clinic

for
Multiple Sclerosis
Location: Atlanta GA
Sponsor: Shepherd Center, Atlanta GA

Sex: All

Age: 18+

Code: NCT07927439

Recruiting
New

Kesimpta (Ofatumumab) Pregnancy Registry

for
Multiple Sclerosis, Pregnancy
Location: La Jolla CA
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT05634967

Recruiting
New

Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis

for
Relapsing Multiple Sclerosis
Location: Salt Lake City UT
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 10 - 17

Code: NCT07220252

Phase 2, Phase 3, Recruiting

PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases

for
Multiple Sclerosis, Alzheimer's Disease
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18 - 70+

Code: NCT02649985

Phase 1, Phase 2, Recruiting

A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis

for
Multiple Sclerosis
Location: East Hanover NJ
Sponsor: Kessler Foundation

Sex: All

Age: 18 - 70

Code: NCT06197685

Recruiting

What is multiple sclerosis?

In MS, the immune system attacks myelin, the insulation around nerve fibers in the brain and spinal cord. Damaged spots, called lesions, slow or block nerve signals, which is why symptoms range from fatigue and numbness to vision problems and trouble walking. Symptoms and pace differ so much between people that MS is often called a disease with a thousand faces. It is not contagious, and it is not directly inherited. Worldwide about 2.9 million people live with MS, someone is diagnosed roughly every five minutes, and the average age at diagnosis is 32.

Research in this field carries one of the most striking findings in modern medicine: a 2022 study of more than 10 million US military members found that infection with the Epstein Barr virus, the common virus behind mononucleosis, raises MS risk 32 times, making it the leading suspected cause. Meanwhile treatment keeps expanding, with more than 20 approved disease modifying therapies, though the progressive forms still have almost none.

Article preview image

Interested in learning more about MS treatment? Read our guide: Multiple Sclerosis Treatment: 20+ Drugs and What's Next

Why Progressive Multiple Sclerosis Still Has Almost No Approved Treatments

The types of MS, and why they matter for trials

Types of multiple sclerosis clinical trials

Who can participate in MS trials?

Do MS trial participants get paid?

How to enroll in a clinical trial for multiple sclerosis